Clinical Efficacy and Safety of Auricular Acupuncture for Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

耳针治疗偏头痛的临床疗效和安全性:随机对照试验的系统评价和荟萃分析

阅读:3

Abstract

BACKGROUND: Migraine is a prevalent and debilitating neurological disorder that results in significant disability and imposes a substantial socioeconomic burden. Auricular Acupuncture (AA) has emerged as a potential therapeutic intervention for alleviating migraine symptoms. Although AA is extensively utilized clinically to treat migraines, a reanalysis investigating its benefits and risks, whose studies were conducted exclusively in China, indicated that notable enhancements in four outcomes relative to controls were achieved by AA. METHODS: We conducted a systematic review and meta-analysis of Randomized Controlled Trials (RCTs) to evaluate the efficacy and safety of AA for migraine. Eight databases were searched from inception to April 18, 2025. Sensitivity and subgroup analyses were performed to evaluate the robustness of the findings and to identify potential sources of heterogeneity. All results were assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Data analyses were conducted using Review Manager 5.4. RESULTS: Specifically, the visual analog scale (VAS) showed a mean difference (MD) of -0.65 (95% Confidence Intervals (CI): -0.86, -0.43; p<0.001) in ten RCTs involving 766 participants were included. Additionally, migraine attack frequency demonstrated an MD of -0.49 (95% CI: -0.59, -0.40; p<0.001) and attack duration had an MD of -0.58 (95% CI: -0.64, -0.52; p<0.001). The clinical effectiveness rate (CER) was reflected in a relative risk of 1.17 (95% CI: 1.10, 1.25; p<0.001). CONCLUSION: Research evidence indicates that AA offers both efficacy and safety in the treatment of migraines. However, inferences resulting from this investigation face constraints arising from the methodological robustness of trials incorporated herein. To better define the role of AA in clinical guidelines, additional high-quality RCTs with expanded scope of population, standardized protocols and extended follow-up periods are required. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251028201.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。